Additionally, osteosarcoma cells exploit immune checkpoint pathways, such as PD-1/PD-L1, CTLA-4, lymphocyte activation gene-3(LAG-3), and T cell immunoglobulin and mucin domain-containing protein 3(TIM-3), to evade immune surveillance. The gene discussed is HAVCR2; the disease is osteosarcoma.